Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Immunogenicity Objective To evaluate the antibody response to each influenza vaccine antigen after vaccination with the aTIV vaccine, as measured by single radial hemolysis (SRH) or hemagglutination inhibition (HI) assay in accordance with Guidance CPMP/BWP/214/96 Safety Objective To evaluate the safety of aTIV in adult subjects ≥65 years of age in compliance with the requirements of the current European Union recommendations for clinical trials related to yearly licensing of influenza vaccines (CPMP/BWP/214/96)
Critère d'inclusion
- Influenza